IPO Banner
HomeIPOWindlas Biotech Limited IPO Details

Windlas Biotech Limited IPO Details

- Advertisement -

Windlas Biotech IPO Date, Price, GMP, Review, Allotment, Subscription, Analysis & Documents

About Windlas Biotech

Windlas Biotech is the top five players in the domestic pharmaceutical formulations contract development and manufacturing organization (“CDMO”) industry in India in terms of revenue. With over two decades of experience in manufacturing both solid and liquid pharmaceutical dosage forms and significant experience in providing specialized capabilities, including, high potency, controlled substances and lowsolubility, provide a comprehensive range of CDMO services ranging from product discovery, product development, licensing and commercial manufacturing of generic products, including complex generics, in compliance with current Good Manufacturing Practices (“GMP”) with a focus on improved safety, efficacy and cost.

- Advertisement -

In Fiscal 2020, the market share was approximately 1.5% in terms of revenue in the domestic formulations CDMO industry In addition to providing services and products in the CDMO market, the comany also sell the own branded products in the trade generics and OTC markets as well as export generic products to several countries.

The prevalence of chronic diseases in India has been increasing in the last few years, specifically in certain key therapeutic categories, such as, anti-diabetic, cardiovascular, neuropsychiatry and respiratory therapies, that are treated with ‘multi-drug therapy’ by physicians, i.e. the specific use of two or more drugs for single or multiple chronic conditions in an individual. Moreover, multi-drug therapy has gained importance over the past few years in the healthcare sector and is expected to aid the growth of pharmaceutical consumption

The company have significant experience in developing and manufacturing generic fixed dose combinations. The focus has currently been on launching new complex generic products in the chronic therapeutic category linked to lifestyle related disorders

Important Details – Windlas Biotech

DateDetails
February 19, 2001The company was incorporated as ‘Windlas Biotech Limited’ at New Delhi as a public limited company
March 5, 2001The company received the certificate for commencement of business from the RoC Delhi.
August 5, 2010The registered office of the company was shifted from the state of Delhi to the state of Uttarakhand
March 30, 2016The company was converted into a private limited company and name of the company changed to ‘Windlas Biotech Private Limited’
April 3, 2021The company was converted from a private limited company to a public limited company and the name of the company was changed to ‘Windlas Biotech Limited’.

Objects of the Issue

  1. Purchase of equipment required for (i) capacity expansion of our existing facility at Dehradun Plant – IV; and (ii) addition of injectables dosage capability at our existing facility at Dehradun Plant-II;
  2. Funding incremental working capital requirements of our Company;
  3. Repayment/prepayment of certain of our borrowings; and
  4. General corporate purposes

Windlas Biotech Limited Financials:

Summary of financial Information (Restated Consolidated Statement)

Particulars For the year ended (₹ in million)
  31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 2,961.23 3,384.88 2,981.80
Total income 4,306.95 3,313.39 3,115.25
Profit After Tax 155.70 162.13 638.22

Windlas Biotech IPO Price – Details

DescriptionWINDLAS IPO Details
Public IssueInitial Public offer of [.] Equity Shares of ₹5 (aggregating up to ₹401.54 Cr) comprising a Fresh Issue [.] Eq Shares of ₹5 (aggregating up to ₹165.00 Cr) and an Offer for sale of up to 5,142,067 equity shares
Issue Open  Date04-Aug-21
Issue Close Date06-Aug-21
Issue TypeBook Building
IPO Price Band₹ 448 – ₹ 460
Face Value ₹ 5
Market Lot 30 Equity Shares and in multiples thereof
Minimum Order Quantity 30 Equity Shares
Maximum Subscription Amount
for Retail Investor
Rs. 2,00,000
Listing NSE, BSE
NSE SymbolWINDLAS
IPO Market Timings 10.00 a.m. to 5.00 p.m.

Windlas Biotech IPO DRHP & RHP

Windlas Biotech IPO Lot Size

ApplicationLotsNo of SharesAmount (Rs)
Minimum130 ₹ 13,800
Maximum14420 ₹ 1,93,200

Windlas Biotech IPO Lead Managers

  • SBI Capital Markets Limited
  • DAM Capital Advisors Limited
  • IIFL Securities Limited

Windlas Biotech Registrar

Company Promoters

  • Ashok Kumar Windlass,
  • Hitesh Windlass,
  • Manoj Kumar Windlass
  • Akw Wbl Family Private Trust

Windlas Biotech IPO Allotment Date, Listing Date and other Important Dates

DetailsDate
Bid / Offer Opens on04-Aug-21
Bid / Offer Closes on06-Aug-21
Finalisation of Basis of Allotment11-Aug-21
Initiation of refunds 12-Aug-21
Credit of the Equity Shares13-Aug-21
Commencement of trading – Listing17-Aug-21

Company Corporate Office

705-706, Vatika Professional Point,
Sector-66, Golf Course Extension Road,
Gurgaon 122 001,
Haryana, India;
Tel: +91 124 2821030

Company Registered Office

40/1, Mohabewala Industrial Area,
Dehradun 248 110,
Uttarakhand, India;
Tel: +91 135 6608000
Corporate Office:

Windlas Biotech IPO – FAQS

When Windlas Biotech IPO will open ?

The Windlas Biotech IPO opens on Aug 04, 2021 and closes on Aug 08, 2021

What is the lot size of Windlas Biotech IPO ?

The Windlas Biotech IPO lot size is 30 Shares and the minimum order quantity is 30 Shares.

What is the price band for Windlas Biotech IPO ?

The Windlas Biotech IPO price band at Rs.448 to Rs.460 per share

Who is the Registrar for Windlas Biotech IPO ?

The Registrar is Link Intime India Private Limited

How to apply in Windlas Biotech IPO through UPI?

Check the step by step process here – Click here

Follow us on Telegram for all latest updates

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here